296 related articles for article (PubMed ID: 32110804)
1. Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.
Lu C; Wang X; Zhao X; Xin Y; Liu C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32110804
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
3. HAND2-AS1 Works as a ceRNA of miR-3118 to Suppress Proliferation and Migration in Breast Cancer by Upregulating PHLPP2.
Dong G; Wang X; Jia Y; Jia Y; Zhao W; Zhang J; Tong Z
Biomed Res Int; 2020; 2020():8124570. PubMed ID: 33015182
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MIF-AS1 promotes breast cancer cell proliferation, migration and EMT process through regulating miR-1249-3p/HOXB8 axis.
Ding J; Wu W; Yang J; Wu M
Pathol Res Pract; 2019 Jul; 215(7):152376. PubMed ID: 31097355
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
Zhong L; Zhong X
Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ARAP1-AS1 targets miR-516b-5p/PDE5A axis to facilitate the progression of thyroid cancer.
Du Q; Huang L; Guo W
Anticancer Drugs; 2023 Jul; 34(6):735-746. PubMed ID: 36730555
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ARAP1-AS1 Promotes Bladder Cancer Development by Regulating the miR-3918/KIF20A Axis.
Zhang W; Zhang J; Hu Z; Sun W; Xu L; Chu H; Wang X; Fu Q
Mol Biotechnol; 2022 Nov; 64(11):1259-1269. PubMed ID: 35556220
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
Zhou B; Guo H; Tang J
Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis.
Li Y; Lv M; Song Z; Lou Z; Wang R; Zhuang M
Biomed Pharmacother; 2018 Jul; 103():939-946. PubMed ID: 29710510
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
Fu A; Yu Z; Zhang E; Song J
Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.
Liu J; Pan C; Lu R; Zhang S
Bioengineered; 2022 Mar; 13(3):7868-7880. PubMed ID: 35291911
[TBL] [Abstract][Full Text] [Related]
16. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
[TBL] [Abstract][Full Text] [Related]
17. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
Ye Y; Gu B; Wang Y; Shen S; Huang W
Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
[No Abstract] [Full Text] [Related]
18. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
[TBL] [Abstract][Full Text] [Related]
19. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.
Yao J; Xu F; Zhang D; Yi W; Chen X; Chen G; Zhou E
J Cell Biochem; 2018 Jan; 119(1):680-690. PubMed ID: 28639399
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
Bao G; Huang J; Pan W; Li X; Zhou T
Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
